Quantum Discovery
Quantum Discovery Labs is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.
Quantum@linkedin.com
Contacts: office@q-pharm.com or comment any post on the site. You are welcome!
Quantum on Google+
druglikeness Archive
-
![The goal of drug discovery is to find potent and selective inhibitors for particular targets. A good ligand thus should be small (for better bio-availability) and potent.
The larger is [...]](http://q-pharm.com/wp-content/themes/arras-theme/images/thumbnail.png "Does size matter?")
Does size matter?
Posted on April 23, 2010 | 1 CommentThe goal of drug discovery is to find potent and selective inhibitors for particular targets. A good ligand thus should be small (for better bio-availability) and potent. The larger is [...] -
Do we need those nM-inhibitors?
Posted on November 11, 2009 | 1 CommentIt’s “well known” that we all need to find the stronger inhibitors against any specific therapeutic target as possible. The motivation is that the strongest inhibitors are most probably less [...] -
How drug-like are vendor libraries?
Posted on October 26, 2009 | No CommentsWe use a few chemical compounds vendors in our drug discovery programs (let us call them “Provider I”, “Provider II”, and “Provider III”). Nowadays chemicals providers normally claim about 1M [...] -
Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?
Posted on January 9, 2008 | No CommentsDruglikeness is a qualitative concept used in drug design for an estimate on how “druglike” a prospective compound is. Usually it is estimated from the molecular structure, often even before [...]